CHINA NT PHARMA GROUP COMPANY LIMITED
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
China NT Pharma Group Company Limited
中 國 泰 凌 醫 藥 集 團 有 限 公 司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 01011)
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 22 SEPTEMBER 2014
The Board announces that the Resolution as set out in the Notice was duly passed by the Shareholders by way of poll at the Extraordinary General Meeting held on 22 September 2014.
The board of directors (the "Board") of China NT Pharma Group Company Limited (the "Company") is pleased to announce the poll results of the extraordinary general meeting of the Company (the "Extraordinary General Meeting") held on 22 September 2014.
Reference is made to the circular (the "Circular") and notice of the Extraordinary General Meeting (the "Notice") issued by the Company both dated 4 September 2014 in connection with the proposal for adoption of new share option scheme. Unless the context requires otherwise, capitalized terms used in this announcement shall have the same meanings as those defined in the Circular.
The Board announces that the resolution (the "Resolution") as set out in the Notice was duly passed by the
Shareholders by way of poll at the Extraordinary General Meeting held on 22 September 2014.
The total number of issued Shares of the Company as at the date of the Extraordinary General Meeting was
1,081,956,500 Shares, which was the total number of Shares entitling the Shareholders to attend and vote for or against the proposed Resolution. There was no Share of the Company entitling the Shareholders to attend
but vote only against the Resolution proposed at the Extraordinary General Meeting. No person was required to abstain from voting on the Resolution proposed at the Extraordinary General Meeting and no party has stated its intention in the Circular to vote against the Resolution proposed at the Extraordinary General
Meeting or to abstain from voting.
The Company's auditor, Crowe Horwath (HK) CPA Limited acted as the scrutineer for counting of votes at the Extraordinary General Meeting.
1
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING
The Board is pleased to announce that the Resolution has been duly passed by the Shareholders by way of poll at the Extraordinary General Meeting and the details of poll results are as follows:
Ordinary Resolution | Number of Votes (%) | Total Number of Votes | |
Ordinary Resolution | For | Against | Total Number of Votes |
To adopt the New Share Option Scheme (ordinary resolution as set out in the Notice). | 505,070,500 (100.00%) | 0 (0.00%) | 505,070,500 |
As more than 50% of votes were cast in favor of the resolution, the resolution was duly passed as an ordinary resolution. |
By order of the Board
China NT Pharma Group Company Limited
Ng Tit
Chairman
Hong Kong, 22 September 2014
As at the date of this announcement, the executive director of the Company is Mr. Ng Tit; the non-executive directors of the Company are Ms. Chin Yu, Dr. Qian Wei and Mr. Wang Fan; and the independent non-executive directors of the Company are Mr. Yue Nien Martin Tang, Mr. Patrick Sun and Dr. Lap-Chee
Tsui.
2
|
distributed by
|
